| Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial. | |
| | |
MedLine Citation:
|
PMID: 23187956 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background/objectives:Cardiovascular disease (CVD) is the leading cause of death in the United States and the world. Clinical trials have suggested that soybean protein lowers lipids and blood pressure. The effect of soybean protein on novel CVD risk factors has not been well studied. The objective of this study was to examine the effect of soybean protein on biomarkers of inflammation, endothelial dysfunction and adipocytokines.Subjects/methods:The effect of 8 weeks of 40 g of soybean protein supplement (89.3 mg isoflavones), 40 g of milk protein supplement and 40 g of complex carbohydrate placebo was examined in a randomized, placebo-controlled, double-blind, three-phase crossover trial among adults in New Orleans, Louisiana and Jackson, Mississippi. Plasma levels of inflammation biomarkers (C-reactive protein, interleukin-6, tumor necrosis factor-α), endothelial dysfunction biomarkers (E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, thrombomodulin) and adipocytokines (high-molecular weight adiponectin, leptin, resistin) were measured at baseline and at the end of each intervention using immunoturbidimetric and enzyme-linked immunosorbent assay techniques.Results:Soy protein supplementation resulted in a significant mean net change (95% confidence interval) in plasma E-selectin of -3.93 ng/ml (-7.05 to -0.81 ng/ml; P=0.014) compared with milk protein, and in plasma leptin of -2089.8 pg/ml (-3689.3 to -490.3 pg/ml; P=0.011) compared with carbohydrate. There were no significant changes in any other risk factors.Conclusions:Soy protein supplementation may reduce levels of E-selectin and leptin. Further research is warranted to investigate the mechanisms through which protein may confer protective effects on novel CVD risk factors.European Journal of Clinical Nutrition advance online publication, 28 November 2012; doi:10.1038/ejcn.2012.186. |
| | |
Authors:
|
C M Rebholz; K Reynolds; M R Wofford; J Chen; T N Kelly; H Mei; P K Whelton; J He |
Related Documents
:
|
23303686 - Intact protein profiling in breast cancer biomarker discovery: protein identification i... 23098276 - Characterization of staphylococcus aureus essb, an integral membrane component of the t... 22940106 - Deletion of a single helix from the transmembrane domain causes large changes in membra... 17094086 - Polyribosomes are increased in spines of ca1 dendrites 2 h after the induction of ltp i... 18685446 - Inherited protein c deficiency with acute ischemic stroke in a young adult: a case report. 5978546 - A study of rubidium accumulation in euglena gracillis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-11-28 |
Journal Detail:
|
Title: European journal of clinical nutrition Volume: - ISSN: 1476-5640 ISO Abbreviation: Eur J Clin Nutr Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8804070 Medline TA: Eur J Clin Nutr Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomiz...
Next Document: Ruthenium(ii) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.